Finally, the metabolic NAFLD group showed characteristics associated with insulin resistance, whereas the PNPLA3 NAFLD group did not, despite having comparable total liver fat (Luukkonen et al., 2016). The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.